About Achillion
Achillion is a company based in New Haven (United States) founded in 1998 was acquired by Alexion in October 2019.. Achillion has raised $41 million across 1 funding round from investors including Alexion, Schroders and GE Capital. Achillion operates in a competitive market with competitors including Eiger BioPharmaceuticals, Aligos Therapeutics, AusperBio, Ascentage Pharma and Bluejay Therapeutics, among others.
- Headquarter New Haven, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Funding Insights of Achillion
Achillion has successfully raised a total of $41M through 1 strategic funding round. The most recent funding activity was a Series C round of $41 million completed in January 2002. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series C — $41.0M
-
First Round
First Round
(28 Jan 2002)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2002 | Amount | Series C - Achillion | Valuation | Bear Stearns Companies |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Achillion
Achillion has secured backing from 9 investors, including institutional and venture fund investors. Prominent investors backing the company include Alexion, Schroders and GE Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Venture capital firm investing in life science and biotechnology sectors
|
Founded Year | Domain | Location | |
|
Venture capital services for biotech, IT, and innovative sectors in Connecticut.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Achillion
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Achillion
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Achillion Comparisons
Competitors of Achillion
Achillion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Eiger BioPharmaceuticals, Aligos Therapeutics, AusperBio, Ascentage Pharma and Bluejay Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of antiviral agents against targets in the treatment of hepatitis
|
|
| domain | founded_year | HQ Location |
Developer of therapies to treat hepatologic diseases and viral infections
|
|
| domain | founded_year | HQ Location |
Therapies for chronic hepatitis B and infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Small molecule drugs for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Therapeutics for infectious diseases treatment are developed.
|
|
| domain | founded_year | HQ Location |
Small-molecule antiviral therapeutics for hepatitis C are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Achillion
Frequently Asked Questions about Achillion
When was Achillion founded?
Achillion was founded in 1998 and raised its 1st funding round 4 years after it was founded.
Where is Achillion located?
Achillion is headquartered in New Haven, United States. It is registered at New Haven, Connecticut, United States.
Who is the current CEO of Achillion?
Milind Deshpande is the current CEO of Achillion.
Is Achillion a funded company?
Achillion is a funded company, having raised a total of $41M across 1 funding round to date. The company's 1st funding round was a Series C of $41M, raised on Jan 28, 2002.
What does Achillion do?
Achillion Pharmaceuticals was founded in 1998 and is based in New Haven, United States, within the biotechnology sector. Focus is placed on developing oral drugs for chronic Hepatitis C, with the lead candidate advancing through phase II trials in partnership with Janssen. An additional Factor D inhibitor is under early-stage evaluation for paroxysmal nocturnal hemoglobinuria, dry age-related macular degeneration, and chronic obstructive pulmonary disease.
Who are the top competitors of Achillion?
Achillion's top competitors include Eiger BioPharmaceuticals, AusperBio and Finch Therapeutics.
Who are Achillion's investors?
Achillion has 9 investors. Key investors include Alexion, Schroders, GE Capital, Atlas Venture, and Bear Stearns Companies.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.